TA Associates has completed a strategic growth investment in Synokem Pharmaceuticals, enhancing the company's capabilities and market reach in the expanding Indian pharmaceutical sector.

Information on the Target

Synokem Pharmaceuticals Ltd. ("Synokem"), founded in 1983 by Mr. J.M. Arora, is a prominent contract development and manufacturing organization (CDMO) in India. The company specializes in producing branded generic formulations for the domestic market and has a robust export business that delivers products to over 30 countries globally. Headquartered in New Delhi, Synokem has dedicated manufacturing and research & development facilities located in Haridwar, India.

Over the years, Synokem has established a strong reputation for innovation in the pharmaceutical sector, consistently delivering first-to-market products. This commitment to excellence has fostered enduring relationships with a diverse client base, thereby reinforcing its position as a leading player in the industry.

Industry Overview in India

The Indian pharmaceutical industry is one of the largest globally and is projected to experience substantial growth in the coming years. Factors contributing to this expansion include an increasing demand for affordable healthcare, s